Latest SEC filings

Heartflow CFO Vikram Verghese sold 24,345 shares for $1,230,742 in two open-market tranches on September 17-18, executed under a pre-arranged 10b5-1 plan.

• Sale split across two tranches: 7,579 shares at $50.11 on 09/17/2026 and 16,766 shares at $50.75 on 09/18/2026.
• Verghese's direct common stock holding after the reported transactions is 155,183 shares.

Heartflow CFO Vikram Verghese sold 34,975 shares across three open-market trades on September 11-15, 2026 for $1,751,611 under a pre-arranged 10b5-1 plan.

• Sale executed in three tranches: 29,714 shares at $50.06, 4,593 at $50.24 and 668 at $50.01
• All sales made under a pre-arranged Rule 10b5-1 plan

Heartflow CEO John C.M. Farquhar sold 38,900 shares for $1,819,604.68 in open-market transactions on 10 and 11 September 2026 under a pre-arranged 10b5-1 plan.

• Two tranches: 35,010 shares at $46.42 on 09/10/2026 and 3,890 shares at $50.00 on 09/11/2026.
• Sale executed under a Rule 10b5-1 pre-arranged trading plan, so the timing was not discretionary.

CFO Vikram Verghese sold 6,640 shares of common stock for a total of $332,211.82 under a 10b5-1 plan.

• Insider Vikram Verghese, Chief Financial Officer, sold shares.
• The transaction involved 6,640 shares of common stock.

CFO Vikram Verghese sold 33,416 shares of company stock for a total value of $1,665,796.46 under a 10b5-1 plan.

• Vikram Verghese, Chief Financial Officer, sold shares.
• The total value of shares sold was $1,665,796.46.